Literature DB >> 29613985

11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.

Noriaki Tomura1, Toshiyuki Saginoya, Hiromi Goto.   

Abstract

OBJECTIVE: The aim of this study was to determine the assessment of positron emission tomography-computed tomography using C-methionine (MET PET/CT) for World Health Organization (WHO) grades II and III meningiomas; MET PET/CT was compared with PET/CT using F-fluorodeoxy glucose (FDG PET/CT).
METHODS: This study was performed in 17 cases with residual and/or recurrent WHO grades II and III meningiomas. Two neuroradiologists reviewed both PET/CT scans. For agreement, the κ coefficient was measured. Difference in tumor-to-normal brain uptake ratios (T/N ratios) between 2 PET/CT scans was analyzed. Correlation between the maximum tumor size and T/N ratio in PET/CT was studied.
RESULTS: For agreement by both reviewers, the κ coefficient was 0.51 (P < 0.05). The T/N ratio was significantly higher for MET PET/CT (3.24 ± 1.36) than for FDG PET/CT (0.93 ± 0.44) (P < 0.01). C-methionine ratio significantly correlated with tumor size (y = 8.1x + 16.3, n = 22, P < 0.05), but FDG ratio did not
CONCLUSIONS: C-methionine PET/CT has superior potential for imaging of WHO grades II and III meningiomas with residual or recurrent tumors compared with FDG PET/CT.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29613985     DOI: 10.1097/RCT.0000000000000729

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

Review 1.  Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications.

Authors:  Riccardo Laudicella; Domenico Albano; Salvatore Annunziata; Diletta Calabrò; Giovanni Argiroffi; Elisabetta Abenavoli; Flavia Linguanti; Domenico Albano; Antonio Vento; Antonio Bruno; Pierpaolo Alongi; Matteo Bauckneht
Journal:  Cancers (Basel)       Date:  2019-09-22       Impact factor: 6.639

2.  Study on intracranial meningioma using PET ligand investigation during follow-up over years (SIMPLIFY).

Authors:  Hanne-Rinck Jeltema; Marnix R Jansen; Adriaan R E Potgieser; Antoinette D I van Asselt; Mart A A M Heesters; Anouk van de Hoorn; Andor W J M Glaudemans; J Marc C van Dijk
Journal:  Neuroradiology       Date:  2021-03-10       Impact factor: 2.804

3.  Magnetic Resonance Imaging (MRI) Differential Diagnosis of Meningiomas Using ANOVA.

Authors:  Jinhuan Liu; Jun Chen; Yunfei Zha; Yabin Huang; Feifei Zeng
Journal:  Contrast Media Mol Imaging       Date:  2021-07-10       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.